KMA and KPA loudly opposed to Oriental Medical Policy Office.

Published: 2003-07-03 07:01:00

Updated: 2003-07-03 07:01:00

The Korea Pharmaceutical Association (KPA) and Korea Medical Association (KMA) strongly petitioned in their joint statement to the MOHW on June 27 for the oriental medical policy office to scrap and for the health and medical policy office newly to establish for a balanced health and medical admi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK